Corcept Therapeutics Incorporated (CORT): Price and Financial Metrics

CORT POWR Grades

• CORT scores best on the Quality dimension, with a Quality rank ahead of 99.94% of US stocks.
• The strongest trend for CORT is in Quality, which has been heading up over the past 179 days.
• CORT's current lowest rank is in the Sentiment metric (where it is better than 18.5% of US stocks).

CORT Stock Summary

• The ratio of debt to operating expenses for CORCEPT THERAPEUTICS INC is higher than it is for about just 5.47% of US stocks.
• With a price/sales ratio of 6.98, CORCEPT THERAPEUTICS INC has a higher such ratio than 83.16% of stocks in our set.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.12 for CORCEPT THERAPEUTICS INC; that's greater than it is for just 9.27% of US stocks.
• Stocks that are quantitatively similar to CORT, based on their financial statements, market capitalization, and price volatility, are AOSL, POWI, VLD, PDEX, and SMTC.
• CORT's SEC filings can be seen here. And to visit CORCEPT THERAPEUTICS INC's official web site, go to www.corcept.com.

CORT Valuation Summary

• In comparison to the median Healthcare stock, CORT's price/sales ratio is 33.96% higher, now standing at 7.1.
• Over the past 224 months, CORT's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for CORT.

CORT Growth Metrics

Its 2 year revenue growth rate is now at 13.53%.
• The 4 year price growth rate now stands at 68.97%.
• Its 3 year price growth rate is now at 86.85%.

CORT's revenue has moved up $202,766,000 over the prior 52 months.

The table below shows CORT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	392.027	151.418	112.719
2022-03-31	380.229	177.717	111.844
2021-12-31	365.978	167.892	112.512
2021-09-30	352.891	153.536	106.453
2021-06-30	343.087	135.276	97.607
2021-03-31	340.064	144.123	99.411

CORT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CORT has a Quality Grade of A, ranking ahead of 98.86% of graded US stocks.
• CORT's asset turnover comes in at 0.616 -- ranking 52nd of 681 Pharmaceutical Products stocks.
• OTIC, ABT, and AVDL are the stocks whose asset turnover ratios are most correlated with CORT.

The table below shows CORT's key quality metrics over time.